Biopharmaceuticals Contract Manufacturing Market: Industry Analysis and Forecast (2023-2029)


Biopharmaceuticals Contract Manufacturing Market size was valued at US$ 3.09 Bn in 2022 and the total revenue is expected to grow at 9.19% through 2022 to 2029, reaching nearly US$ 5.72 Bn.

The Biopharmaceuticals Contract Manufacturing market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Biopharmaceuticals Contract Manufacturing report also provides trends by market segments, technology, and investment with a competitive landscape.Biopharmaceuticals Contract Manufacturing MarketTo know about the Research Methodology :- Request Free Sample Report

Biopharmaceuticals Contract Manufacturing Market Overview:

A contract manufacturing organization (CMO) is a corporation that provides specialized services from drug production to drug manufacturing to other organizations in the biopharmaceutical industry on a contract basis. This helps large biopharmaceutical firms to outsource some facets of their operations, which may help with scalability or increase revenues for drug discovery and drug development. Antibodies, non-antibody scaffolds, recombinant proteins, fragments, and DNA are all manufactured by separate biopharmaceutical firms from various sources.

The increasing popularity of biologics has resulted in a healthcare paradigm change. The number of biopharmaceutical approvals by the US FDA has gradually increased over the last decade. In particular, the United States authorized a total of 28 biopharmaceutical drugs in 2022 (including monoclonal antibodies, recombinant proteins, and gene therapies). In addition, over 8,000 biological medicinal drugs are currently being tested in clinical trials around the world.

Biopharmaceuticals Contract Manufacturing Market Dynamics:


Drivers:

Biopharmaceuticals are a type of medication. In terms of complexity, behavior, manufacture, and how large molecules behave in the human body, large molecules vary from pharmaceutical small molecules. Making such big molecules is a lot more difficult than making conventional pharmaceuticals. Biopharma is, in particular, a highly technological business with complicated processes that only a few players have fully mastered. Biopharmaceutical firms have been gradually increasing in size for many years, and the prevalence of massive pipeline molecules in clinical trials suggests that this trend will continue.

More than 235 firms currently have contract production facilities for biopharmaceuticals, handling a wide range of biologics. Proteins/peptides, antibodies, and vaccines are among the most popular resources provided by contract manufacturing organizations (CMOs). Furthermore, mammalian cell-based manufacturing is more common than microbial expression systems, and this pattern is expected to continue in the future.

The use of CMOs by major pharmaceutical and biotechnology firms to satisfy variable demand and obtain access to other capabilities is another reason for the industry's continued expansion. Continued market restructuring is another pattern reported by respondents. They also anticipate the entry of new CMOs and the specialization of existing CMOs.

Furthermore, strong advances in research and development, new markets, and consolidation in the pharmaceutical CMO industry is expected to boost biopharmaceuticals contract manufacturing growth during the forecast period.

Biopharmaceuticals Contract Manufacturing Market Segment Analysis:

Based on Product, the biologics product segment led the industry in 2022, with an 80% of revenue sales even though contract manufacturers were crucial to the growth of both biologics and biosimilars. Due to the enormous commercial success of biologics, as shown by the availability of a vast number of FDA-approved biologics on the market, the category will retain its dominant position over the forecast era.

Monoclonal Antibodies (MAb) have the highest market share for biologics in 2022. Due to the high capital requirements for the construction of a MAb factory, contract services for MAb production have accelerated, leading to the segment's expansion.

Based on Source, the mammalian root segment dominated the industry in 2022, with a share of over 59 percent. The industry is expected to expand as a result of an extensive investigation into the use of multiple sources and organisms for biopharmaceutical growth. The primary goal of these studies is to improve biopharmaceutical manufacturing competitiveness and performance. Since a large percentage of biopharmaceutical products in development are mammalian-based, the category will continue to lead during the forecast era.

From 2022 to 2029, the non-mammalian source segment is expected to grow at the fastest pace. E. coli, a non-mammalian cell line, is the most commonly used non-mammalian cell culture for biopharmaceutical processing due to its ease of access and low cost of cultivation.

Based on Service, process automation services dominated the world market with a share of over 33%, in 2022. This is because downstream production needs a lot of money. Furthermore, downstream processes necessitate a high level of focus on final product recovery and purification measures to improve product consistency and avoid waste.

Biopharmaceuticals Contract Manufacturing Market 

CMOs also provided biopharma companies with a wide range of facilities, from cell cultivation to final product packaging. Process production, fill & finish activities, analytical & QC tests, and packaging are among the manufacturing services provided by CMOs.

The analytical & QC studies segment is expected to rise at the fastest rate during the forecast period, owing to rising quality issues and regulatory changes for biopharmaceutical growth. To ensure product purity and protection, new regulations are being implemented for CMOs producing biologics following regulatory requirements.

Biopharmaceuticals Contract Manufacturing Market Regional Insights:

Because of the large number of biopharmaceutical companies with large production capacities and the high demand for biologics in this region, North America is expected to have a substantial market share in the global biopharmaceuticals contract manufacturing market. Furthermore, the increasing focus on superior biopharmaceutical goods, biosimilars, and biopharmaceutical-based research and development activities accounted for a significant percentage of total research and development activities carried out in different industries, which is fueling the overall regional market growth to a large extent.
The market for biopharmaceutical contract manufacturing is expanding, owing to rising biologics demand and increased outsourcing by pharmaceutical firms in the Asia Pacific. In the coming years, increased consolidation in the sector is expected to stifle business growth.

The objective of the report is to present a comprehensive analysis of the global Biopharmaceuticals Contract Manufacturing market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global Biopharmaceuticals Contract Manufacturing market dynamics, structure by analyzing the market segments and project the global Biopharmaceuticals Contract Manufacturing market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Biopharmaceuticals Contract Manufacturing market make the report investor’s guide.

Biopharmaceuticals Contract Manufacturing Market Scope: Inquire before buying






Biopharmaceuticals Contract Manufacturing Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2017 to 2022
Market Size in 2022:
US $ 3.09 Bn.




Forecast Period 2023 to 2029 CAGR:
9.19%
Market Size in 2029:
US $ 5.72 Bn.




 Segments Covered:
by Product
• Biologics
1. Monoclonal Antibodies (MAbs)
2. Recombinant Proteins
3. Vaccines
4. Antisense, RNAi, & Molecular Therapy
• Biosimilars




by Source
• Mammalian
• Non-mammalian




by Service
• Process Development
• Fill & Finish Operations
• Analytical and QC Studies
• Packaging






Biopharmaceuticals Contract Manufacturing Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Biopharmaceuticals Contract Manufacturing Market Key Players

• Boehringer Ingelheim GmbH
• Lonza
• Inno Biologics Sdn Bhd
• Rentschler Biotechnologies GmbH
• JRS Pharma
• AGC Biologics
• ProBioGen
• Fujifilm Diosynth Biotechnologies U.S.A., Inc.
• Toyobo Co., Ltd.
• Samsung BioLogics
• Thermo Fisher Scientific, Inc.
• Binex Co., Ltd.
• WuXi Biologics
• AbbVie, Inc.
• Other Key Players

Frequently Asked Questions:

1. Which region has the largest share in Global Biopharmaceuticals Contract Manufacturing Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Biopharmaceuticals Contract Manufacturing Market?
Ans: The Global Biopharmaceuticals Contract Manufacturing Market is growing at a CAGR of 9.19% during forecasting period 2023-2029.

3. What is scope of the Global Biopharmaceuticals Contract Manufacturing Market report?
Ans: Global Biopharmaceuticals Contract Manufacturing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Biopharmaceuticals Contract Manufacturing Market?
Ans: The important key players in the Global Biopharmaceuticals Contract Manufacturing Market are – Boehringer Ingelheim GmbH, Lonza, Inno Biologics Sdn Bhd, Rentschler Biotechnologies GmbH, JRS Pharma, AGC Biologics, ProBioGen, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Toyobo Co., Ltd., Samsung BioLogics, Thermo Fisher Scientific, Inc., Binex Co., Ltd., WuXi Biologics, AbbVie, Inc., Other Key Players

5. What is the study period of this Market?
Ans: The Global Biopharmaceuticals Contract Manufacturing Market is studied from 2022 to 2029. 




1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Biopharmaceuticals Contract Manufacturing Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2022
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Biopharmaceuticals Contract Manufacturing Market
3.4. Geographical Snapshot of the Biopharmaceuticals Contract Manufacturing Market, By Manufacturer share
4. Global Biopharmaceuticals Contract Manufacturing Market Overview, 2022-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Biopharmaceuticals Contract Manufacturing Market
5. Supply Side and Demand Side Indicators
6. Global Biopharmaceuticals Contract Manufacturing Market Analysis and Forecast, 2022-2029
6.1. Global Biopharmaceuticals Contract Manufacturing Market Size & Y-o-Y Growth Analysis.
7. Global Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
7.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
7.1.1. Biologics
7.1.1.1. Monoclonal Antibodies (MAbs)
7.1.1.2. Recombinant Proteins
7.1.1.3. Vaccines
7.1.1.4. Antisense, RNAi, & Molecular Therapy
7.1.2. Biosimilars
7.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
7.2.1. Mammalian
7.2.2. Non-mammalian
7.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
7.3.1. Process Development
7.3.2. Fill & Finish Operations
7.3.3. Analytical and QC Studies
7.3.4. Packaging
8. Global Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
9.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
9.1.1. Biologics
9.1.1.1. Monoclonal Antibodies (MAbs)
9.1.1.2. Recombinant Proteins
9.1.1.3. Vaccines
9.1.1.4. Antisense, RNAi, & Molecular Therapy
9.1.2. Biosimilars
9.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
9.2.1. Mammalian
9.2.2. Non-mammalian
9.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
9.3.1. Process Development
9.3.1.1. Downstream
9.3.1.2. Upstream
9.3.2. Fill & Finish Operations
9.3.3. Analytical and QC Studies
9.3.4. Packaging
10. North America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
11.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
11.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
11.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
12. Canada Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
12.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
12.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
12.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
13. Mexico Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
13.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
13.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
13.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
14. Europe Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
14.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
14.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
14.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
15. Europe Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
16.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
16.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
16.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
17. France Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
17.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
17.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
17.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
18. Germany Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
18.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
18.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
18.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
19. Italy Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
19.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
19.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
19.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
20. Spain Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
20.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
20.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
20.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
21. Sweden Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
21.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
21.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
21.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
22. CIS Countries Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
22.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
22.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
22.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
23. Rest of Europe Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
23.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
23.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
23.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
24. Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
24.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
24.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
24.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
25. Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
26.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
26.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
26.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
27. India Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
27.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
27.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
27.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
28. Japan Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
28.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
28.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
28.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
29. South Korea Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
29.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
29.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
29.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
30. Australia Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
30.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
30.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
30.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
31. ASEAN Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
31.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
31.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
31.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
32. Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
32.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
32.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
33. Middle East Africa Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
33.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
33.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
33.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
34. Middle East Africa Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
35.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
35.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
35.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
36. GCC Countries Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
36.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
36.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
36.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
37. Egypt Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
37.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
37.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
37.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
38. Nigeria Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
38.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
38.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
38.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
39. Rest of ME&A Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
39.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
39.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
39.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
40. South America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
40.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
40.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
40.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
41. South America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
42.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
42.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
42.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
43. Argentina Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
43.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
43.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
43.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
44. Rest of South America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2022-2029
44.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
44.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029
44.3. Market Size (Value) Estimates & Forecast By Service, 2022-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Biopharmaceuticals Contract Manufacturing Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Sources and R&D Investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
45.3. Company Profile : Key Players
45.3.1. Boehringer Ingelheim GmbH
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Product Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. Lonza
45.3.3. Inno Biologics Sdn Bhd
45.3.4. Rentschler Biotechnologies GmbH
45.3.5. JRS Pharma
45.3.6. AGC Biologics
45.3.7. ProBioGen
45.3.8. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
45.3.9. Toyobo Co., Ltd.
45.3.10. Samsung BioLogics
45.3.11. Thermo Fisher Scientific, Inc.
45.3.12. Binex Co., Ltd.
45.3.13. WuXi Biologics
45.3.14. AbbVie, Inc.
45.3.15. Other Key Players
46. Primary Key Insights
  • INQUIRE BEFORE BUYING